-
HIV/AIDS - Research and Palliative Care
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Lipid nanoparticles with accessible nickel as a vaccine delivery system for single and multiple his-tagged HIV antigens
Original Research
(3264) Views (1099) Full article downloads
Authors: Weili Yan, Anekant Jain, Ronan O’Carra, Jerold G Woodward, et al.
Published Date July 2009
Volume 2009:1(Default) Pages 1 - 11
DOI: http://dx.doi.org/10.2147/HIV.S5729
Weili Yan1, Anekant Jain1, Ronan O’Carra2, Jerold G Woodward3, Wenxue Li4, Guanhan Li4, Avindra Nath4, Russell J Mumper1
1Division of Molecular Pharmaceutics and the Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky; 3Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, USA; 4Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
Abstract: Lipid-based nanoparticles (NPs) with a small amount of surface-chelated nickel (Ni-NPs) were developed to easily formulate the human immunodeficiency virus (HIV) his-tagged Tat (his-Tat) protein, as well as to formulate and co-deliver two HIV antigens (his-p24 and his-Nef) on one particle. Female BALB/c mice were immunized by subcutaneous injection with his-Tat/Ni-NP formulation (1.5 µg his-Tat/mouse) and control formulations on day 0 and 14. The day 28 anti-Tat specific immunoglobulin G titer with his-Tat/Ni-NPs was significantly greater than that with Alum/his-Tat. Furthermore, splenocytes from his-Tat/Ni-NP-immunized mice secreted significantly higher IFN-γ than those from mice immunized with Alum/his-Tat. Although Ni-NPs did not show better adjuvant activity than Tat-coated anionic NPs made with sodium dodecyl sulfate (SDS/NPs), they were less toxic than SDS/NPs. The initial results indicated that co-immunization of mice using his-p24/his-Nef/Ni-NP induced greater antibody response compared to using Alum/his-p24/his-Nef. Co-delivery of two antigens using Ni-NPs also increased the immunogenicity of individual antigens compared to delivery of a single antigen by Ni-NPs. In conclusion, Ni-NPs are an efficient delivery system for HIV vaccines including both single antigen delivery and multiple antigen co-delivery.
Keywords: nanoparticle, nickel, HIV, antigen co-delivery, vaccine
- Interested in being a peer-reviewer?
Click here to register.
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Treatment of drug-resistant tuberculosis
- Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
- Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
- High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India




